Cosmetics Industry Stakeholders Not Thrilled About Senate Reform Bill, And Why Should They Be?

In HBW Insight’s conversations with industry advocates about legislation in the US Senate to reform US cosmetics regulations, frustrations with the process have been palpable. Stakeholders suggest that science and proportionality are taking back seats to politics and that concerns about costs to industry, which ultimately could be passed on to consumers, are not being taken seriously enough.

Cosmetics industry stakeholders are frustrated.

The FDA Safety and Landmark Advancements Act proposed in the US Senate, S. 4348, would dramatically overhaul federal cosmetics regulations,...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Legislation

More from Policy & Regulation